Sjögren's syndrome

Textbook of Pediatric Rheumatology

Volumn , Issue , 2011, Pages 458-465

  Tucker, Lori B ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BC CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882460006     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-6581-4.10028-7     Document Type: Chapter

References (112)

1. Sjögren H. Keratoconjunctivitis sicca. Acta. Ophthalmol. 1933, (Suppl. 2):1-145.
2. Novljan M.P., Rozman B., Jerse M., et al. Comparison of the different classification criteria sets for primary Sjögren's Syndrome. Scand. J. Rheumatol. 2006, 35:463-467.
3. Vitali C., Bombardieri S., Jonsson R., et al. Classification criteria for Sjögren's Syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis 2002, 61:554-558.
4. Vitali C., Bombardieri S., Moutsopoulos H.M.G., et al. Preliminary criteria for the classification of Sjögren's Syndrome. Arthritis Rheum 1993, 36:340-347.
5. Bartunkova J., Sediva A., Vencovsky J., et al. Primary Sjögren's Syndrome in children and adolescents: Proposal for diagnostic criteria. Clin. Exp. Rheumatol. 1999, 17:381-386.
6. Houghton K., Malleson P., Cabral D., et al. Primary Sjögren's Syndrome in children and adolescents: are proposed diagnostic criteria applicable?. J. Rheumatol. 2005, 32:2225-2232.
7. Skopouli F.N., Dafni J., Ioannidis J.P., et al. Clinical evolution, and morbidity and mortality of primary Sjögren's Syndrome. Semin. Arthritis Rheum 2000, 29:296-304.
8. Stiller M., Golder W., Doring E., et al. Primary and secondary Sjögren's Syndrome in children-a comparative study. Clin. Oral Investig 2000, 4:176-182.
9. Civilibal M., Canpolat N., Yurt A., et al. A child with primary Sjögren's Syndrome and a review of the literature. Clin. Pediatr 2007, 46:738-742.
10. Leerdam C.M., Martin H.C., Isaacs D. Recurrent parotitis of childhood. J. Paediatr. Child Health 2005, 41:631-634.
11. Wright G.L., Smith R.J.H., Katz C.D., et al. Benign parotic diseases of childhood. Laryngoscope 1985, 95:915-920.
12. Cohen H.A., Gross S., Nussinovitch M., et al. Recurrent parotitis. Arch. Dis. Child 1992, 67:1036-1037.
13. Hara T., Nagata M., Mizuno Y., et al. Recurrent parotid swelling in children: clinical features useful for differential diagnosis of Sjögren's Syndrome. Acta. Paediatr 1992, 81:547-549.
14. Venables P.J. Management of patients presenting with Sjögren's Syndrome. Best Prac. Res. Clin. Rheumatol. 2006, 20:791-807.
15. Parke A.L. Pulmonary manifestations of primary Sjögren's Syndrome. Rheum. Dis. Clin. N. Am 2008, 34:907-920.
16. Gardiner P., Ward C., Allison A., et al. Pleuropulmonary abnormalities in primary Sjögren's Syndrome. J. Rheumatol. 1993, 20:831-837.
17. Dalvi V., Gonzalez E.B., Lovett L. Lymphocytic interstitial pneumonia in Sjögren's Syndrome: a case report and a review of the literature. Clin. Rheumatol. 2007, 26:1339-1343.
18. Launay D., Hachulla E., Hatron P.Y., et al. Pulmonary arterial hypertension: a rare complication of Sjögren's Syndrome: report of 9 new cases and review of the literature. Medicine 2007, 86:299-315.
19. Houghton K., Cabral D., Petty R., et al. Primary Sjögren's Syndrome in dizygotic adolescent twins: one case with lymphocytic interstitial pneumonia. J. Rheumatol. 2005, 32:1603-1606.
20. Pessler F., Emery H., Dai L., et al. The spectrum of renal tubular acidosis in paediatric Sjögren's Syndrome. Rheumatology (Oxford) 2006, 45:85-91.
21. Johnson S., Hulton S.A., Brundler M.A., et al. End-stage renal failure in adolescence with Sjögren's Syndrome autoantibodies. Pediatr. Nephrol 2007, 22:1793-1797.
22. Segal B., Carpenter A., Walk D. Involvement of nervous system pathways in primary Sjögren's Syndrome. Rheum. Dis. Clin. N. Am 2008, 34:885-906.
23. Meligren S.I., Goransson L.G., Omdal R. Primary Sjögren's Syndrome associated neuropathy. Can. J. Neurol. Sci 2007, 34:280-287.
24. Kumon K., Satake A., Mizumoto M., et al. A case of sensory neuropathy associated with childhood Sjögren's Syndrome. Eur. J. Pediatr 2000, 159:630-631.
25. Rojas-Rodriguez J., Garcia-Carrasco M., Ramirez E.S., et al. Optic neuropathy in a child with primary Sjögren's Syndrome. Rev. Rhum. Engl. Ed 1998, 65:355-357.
26. Gottfried J.A., Finkel T.H., Hunter J.V., et al. Central nervous system Sjögren's Syndrome in a child: case report and review of the literature. J. Child Neurol 2001, 16:683-685.
27. Kobayashi I., Furuta H., Tame A., et al. Complications of childhood Sjögren's Syndrome. Eur. J. Pediatr 1996, 155:890-894.
28. Parke A.L. Sjögren's Syndrome: a women's health problem. J. Rheumatol. 2000, 61:4-5.
29. Neiman A.R., Lee L.A., Weston W.L., et al. Cutaneous manifestations of neonatal lupus without heart block: characteristics of mothers and children enrolled in a national registry. J. Pediatr. 2000, 137:674-680.
30. Amarasena R., Bowman S. Sjögren's Syndrome. Clin. Medicine 2007, 7:53-56.
31. Delaleu N., Jonsson M.V., Appel S., et al. New concepts in the pathogenesis of Sjögren's Syndrome. Rheum. Dis. Clin. N. Am 2008, 34:833-845.
32. Nikolov N.P., Illei G.G. Pathogenesis of Sjögren's Syndrome. Curr. Opin. Rheumatol. 2009, 21:465-470.
33. Nordmark G., Alm G.V., Ronnblom L. Mechanisms of disease: primary Sjögren's Syndrome and the type I interferon system. Nat. Clin. Pract. Rheumatol. 2006, 2:262-269.
34. Scofield R.H. Genetics of systemic lupus erythematosus and Sjögren's Syndrome. Curr. Opin. Rheumatol. 2009, 21:448-453.
35. Routsias J.G., Tzioufas A.G. Sjögren's Syndrome: study of autoantigens and autoantibodies. Clin. Rev. Allergy Immunol 2007, 32:238-251.
36. Triantafyllopoulou A., Moutsopoulos H.M. Persistent viral infection in primary Sjögren's Syndrome: Review and perspectives. Clin. Rev. Allergy Immunol 2007, 32:210-214.
37. Gottenberg J.E., Cagnard N., Lucchesi C., et al. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's Syndrome. Proc. Natl. Acad. Sci. USA 2006, 103:2770-2775.
38. Hjelmervik T.O., Petersen K., Jonassen I., et al. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren's Syndrome patients from healthy control subjects. Arthritis Rheum 2005, 52:1534-1544.
39. Emamian E.S., Leon J.M., Lessard C.J., et al. Peripheral blood gene expression profiling in Sjögren's Syndrome. Genes Immunol 2009, 10:285-296.
40. Lavie F., Miceli-Richard C., Ittah M., et al. B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjögren's Syndrome. Scand. J. Immunol 2008, 67:185-192.
41. Ittah M., Miceli-Richard C., Gottenberg J.E., et al. Viruses induce high expression of BAFF by salivary gland epithelial cells through TLR- and type-I IFN-dependant and independent pathways. Eur. J. Immunol 2008, 38:1058-1064.
42. Mcguirt W.F., Whang C., Moreland W. The role of parotid biopsy in the diagnosis of pediatric Sjögren's Syndrome. Arch. Otolaryngol Head Neck Surg 2002, 128:1279-1281.
43. Ramos-Casals M., Solans R., Rosas J., et al. Primary Sjögren's Syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine 2008, 87:210-219.
44. Schall G.L., Anderson L.G., Wolf R.O., et al. Xerostomia in Sjögren's Syndrome. Evaluation by serial salivary scintigraphy. JAMA 1971, 216:2109-2116.
45. Ramos-Casals M., Brito-Zeron P., Perez-de-lis M., et al. Clinical and prognostic significance of parotid scintigraphy in 405 patients with primary Sjögren's Syndrome. J. Rheumatol 2010, 37(3):585-591.
46. Milic V.D., Petrovic RR., Boricic I.V. Diagnostic value of salivary gland ultrasonographic scoring system in primary Sjögren's Syndrome: a comparison with scintigraphy and biopsy. J. Rheumatol 2009, 36(7):1495-1500.
47. Caporali P., Bonacci E., Epis O., et al. Safety and usefulness of minor salivary gland biopsy: Retrospective analysis of 502 procedures performed at a single center. Arthritis Rheum 2008, 59:714-720.
48. Rihl M., Ulbricht K., Schmidt R.E., et al. Treatment of sicca symptoms with hydroxychloroquine in patients with Sjögren's Syndrome. Rheumatology (Oxford) 2009, 48:796-799.
49. Carsons S.E. Issues relating to clinical trials of oral and biologic disease-modifying agents for Sjögren's Syndrome. Rheum. Dis. Clin. N. Am 2008, 34:1011-1023.
50. Fox P.C., Datiles M., Atkinson J.C., et al. Prednisone and piroxicam for treatment of primary Sjögren's Syndrome. Clin. Exp. Rheumatol. 1993, 11:149-156.
51. Skopouli F.N., Jagiello P., Tsifetaki N., et al. Methotrexate in primary Sjögren's Syndrome. Clin. Exp. Rheumatol. 1996, 14:555-558.
52. Sankar V., Brennan M.T., Kok M.R., et al. Etanercept in Sjögren's Syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial. Arthritis Rheum 2004, 50:2240-2245.
53. Steinfeld S.D., Demols P., Salmon I., et al. Infliximab in patients with primary Sjögren's Syndrome: a pilot study. Arthritis Rheum 2001, 44:2371-2375.
54. Isaksen K., Jonsson R., Omdal R. Anti-CD20 treatment in primary Sjögren's Syndrome. Scand. J. Immunol 2008, 68:554-564.
55. Voulgarelis M., Skopouli F.N. Clinical, immunologic, and molecular factors predicting lymphoma development in Sjögren's Syndrome patients. Clin. Rev. Allergy Immunol 2007, 32:265-274.
56. Kassan S.S., Thomas T.L., Moutsopoulos H.M., et al. Increased risk of lymphoma in sicca syndrome. Ann. Intern. Med 1978, 89:888-892.
57. Sjögren H. Keratoconjunctivitis sicca. Acta. Ophthalmol. 1933, (Suppl. 2):1-145.
58. Novljan M.P., Rozman B., Jerse M., et al. Comparison of the different classification criteria sets for primary Sjögren's Syndrome. Scand. J. Rheumatol. 2006, 35:463-467.
59. Vitali C., Bombardieri S., Jonsson R., et al. Classification criteria for Sjögren's Syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis 2002, 61:554-558.
60. Vitali C., Bombardieri S., Moutsopoulos H.M.G., et al. Preliminary criteria for the classification of Sjögren's Syndrome. Arthritis Rheum 1993, 36:340-347.
61. Bartunkova J., Sediva A., Vencovsky J., et al. Primary Sjögren's Syndrome in children and adolescents: Proposal for diagnostic criteria. Clin. Exp. Rheumatol. 1999, 17:381-386.
62. Houghton K., Malleson P., Cabral D., et al. Primary Sjögren's Syndrome in children and adolescents: are proposed diagnostic criteria applicable?. J. Rheumatol. 2005, 32:2225-2232.
63. Skopouli F.N., Dafni J., Ioannidis J.P., et al. Clinical evolution, and morbidity and mortality of primary Sjögren's Syndrome. Semin. Arthritis Rheum 2000, 29:296-304.
64. Stiller M., Golder W., Doring E., et al. Primary and secondary Sjögren's Syndrome in children-a comparative study. Clin. Oral Investig 2000, 4:176-182.
65. Civilibal M., Canpolat N., Yurt A., et al. A child with primary Sjögren's Syndrome and a review of the literature. Clin. Pediatr 2007, 46:738-742.
66. Leerdam C.M., Martin H.C., Isaacs D. Recurrent parotitis of childhood. J. Paediatr. Child Health 2005, 41:631-634.
67. Wright G.L., Smith R.J.H., Katz C.D., et al. Benign parotic diseases of childhood. Laryngoscope 1985, 95:915-920.
68. Cohen H.A., Gross S., Nussinovitch M., et al. Recurrent parotitis. Arch. Dis. Child 1992, 67:1036-1037.
69. Hara T., Nagata M., Mizuno Y., et al. Recurrent parotid swelling in children: clinical features useful for differential diagnosis of Sjögren's Syndrome. Acta. Paediatr 1992, 81:547-549.
70. Venables P.J. Management of patients presenting with Sjögren's Syndrome. Best Prac. Res. Clin. Rheumatol. 2006, 20:791-807.
71. Parke A.L. Pulmonary manifestations of primary Sjögren's Syndrome. Rheum. Dis. Clin. N. Am 2008, 34:907-920.
72. Gardiner P., Ward C., Allison A., et al. Pleuropulmonary abnormalities in primary Sjögren's Syndrome. J. Rheumatol. 1993, 20:831-837.
73. Dalvi V., Gonzalez E.B., Lovett L. Lymphocytic interstitial pneumonia in Sjögren's Syndrome: a case report and a review of the literature. Clin. Rheumatol. 2007, 26:1339-1343.
74. Launay D., Hachulla E., Hatron P.Y., et al. Pulmonary arterial hypertension: a rare complication of Sjögren's Syndrome: report of 9 new cases and review of the literature. Medicine 2007, 86:299-315.
75. Houghton K., Cabral D., Petty R., et al. Primary Sjögren's Syndrome in dizygotic adolescent twins: one case with lymphocytic interstitial pneumonia. J. Rheumatol. 2005, 32:1603-1606.
76. Pessler F., Emery H., Dai L., et al. The spectrum of renal tubular acidosis in paediatric Sjögren's Syndrome. Rheumatology (Oxford) 2006, 45:85-91.
77. Johnson S., Hulton S.A., Brundler M.A., et al. End-stage renal failure in adolescence with Sjögren's Syndrome autoantibodies. Pediatr. Nephrol 2007, 22:1793-1797.
78. Segal B., Carpenter A., Walk D. Involvement of nervous system pathways in primary Sjögren's Syndrome. Rheum. Dis. Clin. N. Am 2008, 34:885-906.
79. Meligren S.I., Goransson L.G., Omdal R. Primary Sjögren's Syndrome associated neuropathy. Can. J. Neurol. Sci 2007, 34:280-287.
80. Kumon K., Satake A., Mizumoto M., et al. A case of sensory neuropathy associated with childhood Sjögren's Syndrome. Eur. J. Pediatr 2000, 159:630-631.
81. Rojas-Rodriguez J., Garcia-Carrasco M., Ramirez E.S., et al. Optic neuropathy in a child with primary Sjögren's Syndrome. Rev. Rhum. Engl. Ed 1998, 65:355-357.
82. Gottfried J.A., Finkel T.H., Hunter J.V., et al. Central nervous system Sjögren's Syndrome in a child: case report and review of the literature. J. Child Neurol 2001, 16:683-685.
83. Kobayashi I., Furuta H., Tame A., et al. Complications of childhood Sjögren's Syndrome. Eur. J. Pediatr 1996, 155:890-894.
84. Parke A.L. Sjögren's Syndrome: a women's health problem. J. Rheumatol. 2000, 61:4-5.
85. Neiman A.R., Lee L.A., Weston W.L., et al. Cutaneous manifestations of neonatal lupus without heart block: characteristics of mothers and children enrolled in a national registry. J. Pediatr. 2000, 137:674-680.
86. Amarasena R., Bowman S. Sjögren's Syndrome. Clin. Medicine 2007, 7:53-56.
87. Delaleu N., Jonsson M.V., Appel S., et al. New concepts in the pathogenesis of Sjögren's Syndrome. Rheum. Dis. Clin. N. Am 2008, 34:833-845.
88. Nikolov N.P., Illei G.G. Pathogenesis of Sjögren's Syndrome. Curr. Opin. Rheumatol. 2009, 21:465-470.
89. Nordmark G., Alm G.V., Ronnblom L. Mechanisms of disease: primary Sjögren's Syndrome and the type I interferon system. Nat. Clin. Pract. Rheumatol. 2006, 2:262-269.
90. Scofield R.H. Genetics of systemic lupus erythematosus and Sjögren's Syndrome. Curr. Opin. Rheumatol. 2009, 21:448-453.
91. Routsias J.G., Tzioufas A.G. Sjögren's Syndrome: study of autoantigens and autoantibodies. Clin. Rev. Allergy Immunol 2007, 32:238-251.
92. Triantafyllopoulou A., Moutsopoulos H.M. Persistent viral infection in primary Sjögren's Syndrome: Review and perspectives. Clin. Rev. Allergy Immunol 2007, 32:210-214.
93. Gottenberg J.E., Cagnard N., Lucchesi C., et al. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's Syndrome. Proc. Natl. Acad. Sci. USA 2006, 103:2770-2775.
94. Hjelmervik T.O., Petersen K., Jonassen I., et al. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren's Syndrome patients from healthy control subjects. Arthritis Rheum 2005, 52:1534-1544.
95. Emamian E.S., Leon J.M., Lessard C.J., et al. Peripheral blood gene expression profiling in Sjögren's Syndrome. Genes Immunol 2009, 10:285-296.
96. Lavie F., Miceli-Richard C., Ittah M., et al. B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjögren's Syndrome. Scand. J. Immunol 2008, 67:185-192.
97. Ittah M., Miceli-Richard C., Gottenberg J.E., et al. Viruses induce high expression of BAFF by salivary gland epithelial cells through TLR- and type-I IFN-dependant and independent pathways. Eur. J. Immunol 2008, 38:1058-1064.
98. Mcguirt W.F., Whang C., Moreland W. The role of parotid biopsy in the diagnosis of pediatric Sjögren's Syndrome. Arch. Otolaryngol Head Neck Surg 2002, 128:1279-1281.
99. Ramos-Casals M., Solans R., Rosas J., et al. Primary Sjögren's Syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine 2008, 87:210-219.
100. Schall G.L., Anderson L.G., Wolf R.O., et al. Xerostomia in Sjögren's Syndrome. Evaluation by serial salivary scintigraphy. JAMA 1971, 216:2109-2116.
101. Ramos-Casals M., Brito-Zeron P., Perez-de-lis M., et al. Clinical and prognostic significance of parotid scintigraphy in 405 patients with primary Sjögren's Syndrome. J. Rheumatol 2010, 37(3):585-591.
102. Milic V.D., Petrovic RR., Boricic I.V. Diagnostic value of salivary gland ultrasonographic scoring system in primary Sjögren's Syndrome: a comparison with scintigraphy and biopsy. J. Rheumatol 2009, 36(7):1495-1500.
103. Caporali P., Bonacci E., Epis O., et al. Safety and usefulness of minor salivary gland biopsy: Retrospective analysis of 502 procedures performed at a single center. Arthritis Rheum 2008, 59:714-720.
104. Rihl M., Ulbricht K., Schmidt R.E., et al. Treatment of sicca symptoms with hydroxychloroquine in patients with Sjögren's Syndrome. Rheumatology (Oxford) 2009, 48:796-799.
105. Carsons S.E. Issues relating to clinical trials of oral and biologic disease-modifying agents for Sjögren's Syndrome. Rheum. Dis. Clin. N. Am 2008, 34:1011-1023.
106. Fox P.C., Datiles M., Atkinson J.C., et al. Prednisone and piroxicam for treatment of primary Sjögren's Syndrome. Clin. Exp. Rheumatol. 1993, 11:149-156.
107. Skopouli F.N., Jagiello P., Tsifetaki N., et al. Methotrexate in primary Sjögren's Syndrome. Clin. Exp. Rheumatol. 1996, 14:555-558.
108. Sankar V., Brennan M.T., Kok M.R., et al. Etanercept in Sjögren's Syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial. Arthritis Rheum 2004, 50:2240-2245.
109. Steinfeld S.D., Demols P., Salmon I., et al. Infliximab in patients with primary Sjögren's Syndrome: a pilot study. Arthritis Rheum 2001, 44:2371-2375.
110. Isaksen K., Jonsson R., Omdal R. Anti-CD20 treatment in primary Sjögren's Syndrome. Scand. J. Immunol 2008, 68:554-564.
111. Voulgarelis M., Skopouli F.N. Clinical, immunologic, and molecular factors predicting lymphoma development in Sjögren's Syndrome patients. Clin. Rev. Allergy Immunol 2007, 32:265-274.
112. Kassan S.S., Thomas T.L., Moutsopoulos H.M., et al. Increased risk of lymphoma in sicca syndrome. Ann. Intern. Med 1978, 89:888-892.